Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Vitamin D resistant rickets, most often X-linked hypophosphatemia, usually does not improve with standard vitamin D supplements because the root problem is phosphate loss through the kidneys rather than a simple deficiency. Next steps generally involve blood and urine testing for phosphate, alkaline phosphatase, calcium, PTH and FGF23, leg and wrist X-rays, genetic testing, and referral to an endocrinologist, nephrologist or metabolic bone specialist, with treatment options that may include oral phosphate plus active vitamin D (calcitriol) or targeted therapy such as burosumab. Ongoing dental care, orthopedic monitoring for bowed legs, growth tracking and periodic kidney and calcium checks are also part of long term management. Because the right plan depends on age, genetic cause, severity and prior treatment response, there are several important factors to consider before deciding what to do next, so see below to understand more.
Bone pain, delayed growth, dental abscesses and leg deformity can point to several different conditions, and sorting through them alone is difficult. A free, instant, online <a href="https://ubiehealth.com
Vitamin D resistant rickets is a rare disorder in which the body cannot use vitamin D effectively to build and strengthen bones. Unlike classic rickets caused by vitamin D deficiency, this form often stems from genetic changes affecting phosphate handling in the kidneys and bone mineralization. Early recognition and the right next steps can help manage symptoms, improve bone health, and support growth.
Vitamin D resistant rickets is most often linked to disorders of phosphate regulation. Key features include:
Common types:
Each type disrupts the balance of phosphate and vitamin D needed for healthy bone formation.
Symptoms often appear in early childhood but may vary in severity:
Because symptoms overlap with other bone disorders, careful evaluation is needed.
A thorough assessment includes:
Laboratory Tests
Imaging
Genetic Testing
Because vitamin D resistant rickets often runs in families:
Early detection in family members can prompt monitoring before symptoms worsen.
Managing vitamin D resistant rickets usually involves a multidisciplinary team:
Regular communication between specialists ensures coordinated care and adjusts treatment as your child grows.
The primary goals are to normalize phosphate levels, support bone mineralization, and relieve pain. Common approaches:
When to consider specialist treatments:
Regular follow-up is essential to balance benefits and potential side effects:
Your care team will adjust supplement doses, vitamin D analogs, or burosumab based on lab results and symptoms.
While medical therapy is key, these steps help optimize bone health:
Work with a registered dietitian to tailor meal plans and ensure nutritional needs are met.
Severe bone deformities or fractures may require:
Early referral to orthopedic and dental specialists can prevent complications and improve quality of life.
A chronic condition can impact daily life. Consider:
Building a support network helps children and caregivers cope and thrive.
If you notice any of the following, contact your healthcare team promptly:
For a free, online symptom check, using the doctor approved Ubie Symptom Checker, visit https://ubiehealth.com/.
If you suspect vitamin D resistant rickets or have concerns about growth, bone pain, or family history:
Always speak to a doctor about anything that could be life threatening or serious. Early intervention can prevent complications and give your child the best possible outcome.
Vitamin D resistant rickets presents unique challenges, but with a clear plan—specialist care, targeted therapies, and ongoing support—you can take meaningful next steps toward healthier bones and stronger growth.
(References)
* Baroncelli GI, Toschi B, Bertelloni S. Hypophosphatemic rickets. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197.
* Bitzan M, Goodyer PR. Hypophosphatemic Rickets. Pediatr Clin North Am. 2019 Feb;66(1):179-207. doi: 10.1016/j.pcl.2018.09.004. PMID: 30454743.
* Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.
* Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488. PMID: 35981346; PMCID: PMC9759174.
* Miller WL, Imel EA. Rickets, Vitamin D, and Ca/P Metabolism. Horm Res Paediatr. 2022;95(6):579-592. doi: 10.1159/000527011. Epub 2022 Nov 29. PMID: 36446330.
* Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr. 2023 Jun;90(6):574-581. doi: 10.1007/s12098-023-04538-4. Epub 2023 Apr 19. PMID: 37074534; PMCID: PMC10212799.
* Kamenický P, Briot K, Munns CF, Linglart A. X-linked hypophosphataemia. Lancet. 2024 Aug 31;404(10455):887-901. doi: 10.1016/S0140-6736(24)01305-9. Epub 2024 Aug 21. PMID: 39181153.
* Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15. PMID: 39814982.
* Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rao C, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Guyatt G, Brandi ML, Khan AA. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jun 17;110(7):2055-2070. doi: 10.1210/clinem/dgaf093. PMID: 39960858; PMCID: PMC12187519.
* Böckmann I, Haffner D. The Diagnosis and Therapy of XLH. Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w. Epub 2025 Apr 28. PMID: 40295317; PMCID: PMC12037658.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.